SLC2A1 and neoplasm: To confirm that tumor neutrophils indeed exhibited a pronounced glycolytic signature as well as enhanced HIF-1α expression, we assessed the protein expression of glucose transporter 1 (GLUT1; a glycolytic marker) and HIF-1α by immunofluorescence.